Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. announced it has extended the termination date for completing its initial business combination with United Hydrogen from July 6, 2026 to August 6, 2026. To fund the extension, $34,330.96 was deposited into the company’s public trust account on July 6, 2026. The company also issued an unsecured promissory note dated July 6, 2026, in the principal amount of $34,330.96 to Aimei Health Ltd. (a Cayman Islands exempted company).

Key Details

• Extension: one-month extension of the SPAC termination date from July 6, 2026 to August 6, 2026 (the 20th extension allowed under the company’s Amended and Restated Articles).
• Extension payment: $34,330.96 deposited into the public shareholders’ trust account; formula is the lesser of $80,000 total or $0.033 per public share per monthly extension.
• Promissory Note: unsecured, non‑interest bearing, principal $34,330.96 payable upon consummation of the business combination with United Hydrogen.
• Conversion right: the payee (Aimei Health Ltd.) may convert the note, in whole or in part, into private units at $10.00 per unit (each unit = 1 ordinary share + right to 1/5 of one ordinary share) by giving at least two business days’ written notice prior to closing the business combination.

Why It Matters
The extension delays the deadline for completing the planned business combination, giving the company another month to close the transaction. The promissory note creates a company liability of $34,330.96 that is payable at closing unless converted into private units, which could affect the company’s capitalization (potential private placement units at $10 each). Repeated extensions (this is the 20th permitted) signal continued uncertainty about timing of the merger; investors should watch for updates on the business combination with United Hydrogen and any conversion or repayment of the promissory note.